Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Pulmonary Artery
Bronchial Artery
Pulmonary Vein
Azygous Vein
Left Heart
Right HeartBronchial
Vein
Broncho-pulmonary Vein
Broncho-pulmonary Anastomosis
Normal Pulmonary and Bronchial Blood Flow
Alveoli
Alveoli
Alveoli
Farid Jalali MD / May 2020In Normal Lung Circulation, Bronchopulmonary Anastomoses Do Not Have a Clinically Significant Role Unless Either Pulmonary or Bronchial Perfusion is Disturbed
Click For Next Slide
PA
BA
PV
AV
LA
RABV
BPVBPA
In Pulmonary Embolism, Bronchopulmonary Anastomoses (BPA) Allow Diversion of Systemic Oxygenated Perfusion (Black Arrows) from Bronchial to Pulmonary Circulation To Prevent Lung Ischemia
PulmonaryEmbolism
Pulmonary Embolism
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
ALV
ALV
ALV
Deoxygenated Blood
Oxygenated Blood
ShuntPrevents
Lung Ischemia
Click For Next Slide
Farid Jalali MD / May 2020
PA
BA
PV
AV
LA
RABV
BPVBPA
Step 1
COVID19Acute Lung Injury
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Alveolar Capillary Near-Occlusive DiseaseAngiotensin II Excess Mediated
VasoconstrictionMicrothrombi ALV
ALV
ALV
SARS-CoV-2 Action on Alveolar Capillary Endothelium Mediated by Ang II Excess Results in a Progressive Alveolar Capillary Occlusive Disease
Click For Next Slide
Farid Jalali MD / May 2020
PA
BA
PV
AV
LA
RABV
BPVBPA
Step 2
COVID19Acute Lung Injury
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
ALV
ALV
ALV
With Locally Impaired Pulmonary Circulation, Bronchopulmonary Anastomoses Shunt Oxygenated Blood from Bronchial to Pulmonary Circulation Per Yellow Arrows
Alveolar Capillary Near-Occlusive DiseaseAngiotensin II Excess Mediated
VasoconstrictionMicrothrombi
ShuntPrevents
Lung Ischemia Click For Next Slide
Farid Jalali MD / May 2020
PA
BA
PV
AV
LA
RABV
BPVBPA
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Step 3
COVID19Acute Lung Injury
Minimal PerfusionNormal Ventilation
High V/Q MismatchALV
ALV
ALV
As Lung Endothelial Injury Worsens, Alveolar Capillary Vaso-Occlusive Disease Progresses, Resulting in Development of Dead Space Ventilation
Alveolar Capillary Occlusive DiseaseProgressive Vasoconstriction
Progressive Microthrombi
Click For Next Slide
ShuntPrevents
Lung Ischemia
Farid Jalali MD / May 2020
PA
PV
Step 4
COVID19Acute Lung Injury
Minimal PerfusionNormal Ventilation
High V/Q MismatchALV
ALV
As Lung Endothelial Injury Worsens, Alveolar Capillary Vaso-Occlusive Disease Progresses, Resulting in Development of Dead Space Ventilation
Alveolar Capillary Occlusive DiseaseProgressive Vasoconstriction
Progressive Microthrombi Click For Next Slide
Farid Jalali MD / May 2020
DorsalAlveolar Hypocapnia
Alveolar Duct Constriction
V RedistributionTo Areas with Less V/Q Mismatch
NADEL, COLEBATCH, AND OLSEN
FIG. 6. A: anatomic relation between vagal efferent nerves and airways. Large dashed lines extending from vagus nerves to terminal airways indicate possible nervous innervation of these areas. Stimulation of vagus nerves constricts all the airways. In- creased time constant (RC) may lead to transient air retention (indicated by solid lines showing overexpanded alveoli). B: ana- tomic relation between the pulmonary circulation and peripheral airways. R.B. = respiratory bronchiole; A.D. = alveolar duct. Note conspicuous amounts of smooth muscle in peripheral airways relative to total thickness of their walls. Agents in this circulation capable of causing smooth muscle contraction cause these airways to constrict, decreasing pulmonary compliance and expelling air from the lungs (indicated by solid lines showing constricted alveolar duct and “pulling-in” of associated alveoli).
Location of airway constriction after barium sulfate micro- embolism. The combination of increase in pulmonary resistance, decrease in pulmonary compliance, and in- crease in anatomic dead space, which occur after barium sulfate injection, suggests that changes occurred in the peripheral portions of the lungs beyond the anatomic dead space, i.e., the alveoli, alveolar ducts, and respira- tory bronchioles (24, 26). The changes could be due to pulmonary edema, alteration of the surface properties of the alveoli, or contraction of smooth muscle in the peripheral airways.
Although pulmonary edema could explain the de- creased pulmonary compliance, the animals did not show pulmonary edema postmortem. Primary changes in the surface-active material lining the lungs could also account for the changes. However, intravenous isoproterenol, a potent airway smooth-muscle dilator, prevented or decreased the changes in lung mechanics after barium sulfate microembolism, suggesting that contraction of smooth muscle was responsible for the changes.
Our anatomic studies after barium sulfate micro- embolism showed predominant constriction of alveolar ducts and less marked constriction of terminal bron- chioles; the associated alveoli were pulled in toward the alveolar duct (Fig. 5, A and B). An explanation is that the alveolar mouths contain smooth muscle and are part of the alveolar duct skeleton. Other evidence in-
dicates that right heart injection of various drugs capable of causing smooth muscle contraction (e.g., histamine) results in physiologic and anatomic changes similar to those due to barium sulfate microembolism (I 0).
The existence of smooth muscle in the peripheral airways, including alveolar ducts, has been confirmed by many anatomists (15, 24, 26, 32). The pulmonary arterial branches are distributed to the peripheral air- ways (24, 26) and the bronchial arterial branches to the large airways (23, 24). Dunn (I 3) described contraction of smooth muscle of the “atria” or bronchiolar termina- tions and the infundibula after injection of starch emboli in goats. He suggested a reflex connection between the impaction of starch granules in the vessels and spasm of the airway muscle. Binger (4) also described irregular narrowing of bronchiolar lumina after starch emboli with areas of partial atelectasis around the emboli. He be- lieved the smooth-muscle contraction was not significant.
Mechanism of airway constriction after barium sulfate microembolism. The lungs of the cat contain histamine (16); injection of 48/80 (a substance which releases histamine from mast cells) into the right side of the heart results in changes in CL and RL similar to those found after barium sulfate microembolism (I 0). After prior injections of 48/80 and the return to the normal state, the changes in CL and RL induced by barium sulfate were significantly reduced. This suggests that the effects depend on the release of histamine. That histamine re- lease occurs after microembolism of the lung is sug- gested by observations made of cross-circulated dogs: starch embolism of one dog increases the gastric secre- tion of the other dog (I 4, 37). Recent studies indicate that barium sulfate microemboli decrease histamine in the lung tissue (9).
Antihistaminics do not prevent changes in CL and RL in sheep after barium sulfate microembolism (20). How- ever, if barium sulfate releases histamine from a concen- trated source near the peripheral airways, the histamine will reach the nearby muscle cells in high concentration, and intravenously administered antagonists are unlikely to abolish its effects near the site of release.
Histamine has been shown to be released under various circumstances : intravenous injection of cotton-dust ex- tracts releases histamine from the lungs in cats (I) ; these extracts also release histamine from normal human lung tissue in vitro (6). Inhalation of steam appears to release histamine from the lungs in dogs (2).
Kabins et al. (22) have postulated that starch emboli initiate a reflex that stimulates sympathetic efferent nervous activity; pressor amines thus released cause histamine release in the lungs which then results in pulmonary edema. The involvement of sympathetic efferent pathways in the formation of lung edema does not explain the changes in lung mechanics after barium sulfate injection since prior injection of guanethedine did not prevent the change in CL and RL.
Although there is evidence that histamine is responsi- ble for the changes observed after barium sulfate micro-
Preserved Overall Compliance
Alveolar DuctDilation
VentralAlveolar
HypercapniaProtective Physiologic Response
To Avoid Overdistention of Alveoli with Poor Perfusion To Avoid Further Injurious Capillary Vasoconstriction
PA
BA
PV
AV
LA
RABV
BPVBPA
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
OccludingCapillary Bed
Step 5
COVID19Acute Lung Injury
ALV
ALV
ALV
Progressive Occlusion of Alveolar Capillary Bed Results in Backflow of Pulmonary Arteriolar Blood across the Bronchopulmonary Anastomoses along Yellow Arrows
No Evidence of PAH due toFlow Diversion via BPA
High V/Q Mismatch
Click For Next Slide
Farid Jalali MD / May 2020
PA
BA
PV
AV
LA
RABV
BPVBPA
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Step 6
COVID19Acute Lung Injury
Progressive Distention and Back Pressure Buildup in the Direction of Yellow Arrows Causing Hyper-Perfusion in the Intrapulmonary Shunt with Low V/Q Mismatch
ALV
ALV
ALV
Progressive Distention of Pre-Capillary Pulmonary ArterioleUntil It Reaches BPA Will Be Seen
Chest CTA
Bronchial Shunt Drains Across BPV into PV
Click For Next Slide
ShuntPrevents
Lung Ischemia
Farid Jalali MD / May 2020
Increase PA Flow
BA
PV
AV
LA
RABV
BPVIncrease Shunt Flow
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Step 7
COVID19Acute Lung Injury
Factors That Exacerbate Intrapulmonary Shunt PhysiologyIncreased SVR: Valsalva, Systemic VasoconstrictionDecreased PVR: Pulmonary Vasodilators
ALV
ALV
ALV
Both
Click For Next Slide
ShuntPrevents
Lung Ischemia
Farid Jalali MD / May 2020
Reduces Blood Poolingin Dorsal-Predominant Intrapulmonary Shunts
By Gravity
BA
PV
AV
LA
RABV
BPV
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Step 8
COVID19Acute Lung Injury
Prone Position Improves Dorsal-Predominant Intrapulmonary Shunt Physiology
ALV
ALV
ALV
PA
Reduces Shunt FlowClick For
Next Slide
ShuntPrevents
Lung Ischemia
Farid Jalali MD / May 2020
PA
BA
PV
AV
LA
RABV
BPV
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Step 9
COVID19Acute Lung Injury
ALV
ALV
ALV
NO FLOW
Mechanical Ventilation May Accelerate Worsening of High and Low V/Q MismatchDue to Higher Lung Volume (Increased VT, Increased PEEP)
Vascular Resistance ofExtra-Alveolar Vessels
Vascular Resistance ofAlveolar Capillaries
Diminishes AlveolarCapillary Flow
ShuntPreventingIschemia
Occluding
Increases Shunt Flow
Farid Jalali MD / May 2020
ProgressiveVenous
Congestion
1
3
4
1 2 3
Click For Next Slide
Worsens High V/Q Mismatch
Worsens Low V/Q Mismatch
2
4
?
AcceleratedLung Injury
ParenchymalIschemia
Cytokine StormAfter Intubation
PA
BA
PV
AV
LA
RABV
BPV
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Step 10
COVID19Acute Lung Injury
ALV
ALV
ALV
NO FLOW
In Absence of Endothelial Stabilization, Proper Anticoagulation, And Flow Redistribution, Lung Injury Progresses by Worsening High and Low V/Q Mismatch
Diminishing AlveolarCapillary Flow
ShuntPreventingIschemia
Occluding
Increasing Shunt Flow
Click For Next Slide
Farid Jalali MD / May 2020
ProgressiveVenous
Congestion3
42
Worsening High V/Q Mismatch
Worsening Low V/Q Mismatch
ProgressiveLung Injury
1 2 3
Click For Next Slide
4
Diffuse Alveolar Damage
1
ParenchymalIschemia
Endothelial-EpithelialBarrier Breakdown
PA
BA
PV
AV
LA
RABV
BPV
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Step 11
COVID19Acute Lung Injury
ALV
ALV
ALV
NO FLOW
Late Lung Injury is Characterized by Poor Lung ComplianceProgressive Interstitial EdemaProgressive Alveolar Edema and DamageProgressive Bronchial Distortion
BPAClick For
Next Slide
Farid Jalali MD / May 2020
PA
BA
PV
AV
LA
RABV
BPV
BPA: Bronchopulmonary AnastomosisBPV: Bronchopulmonary VeinBA: Bronchial ArteryBV: Bronchial Vein
Step 12
COVID19Acute Lung Injury
ALV
ALV
ALV
Significant Reperfusion Injury May Develop As Well with Microthrombi Resolution by Anticoagulation, Thrombolytics, or via Innate Fibrinolysis
BPA
RESTOREDFLOW
Severely Injured Endothelium High Vascular Permeability
AlveolarEdema
InterstitialEdema
End
Farid Jalali MD / May 2020
Farid Jalali MD / May 2020
• Early endothelial stabilization, before hypoxia sets in, is key to prevent SARS-CoV-2 induced, excess Angiotensin II mediated, intense alveolar capillary vasoconstriction as well as the concomitant pro-inflammatory, pro-thrombotic endothelial milieu, all of which form the basis of lung injury in COVID19.
• Once hypoxia sets in, supportive care should include early and aggressive endothelial stabilization interventions, properly dosed anticoagulation to prevent lung microvascular thrombi, HFNC, and awake prone position to redistribute flow away from the forming dorsal-predominant intrapulmonary shunts.
• Alveolar capillary microvascular thrombi are not a pre-requisite for the severe lung injury in COVID19, but are a clear step in the wrong direction if allowed to be formed.
Take Home Points
Take Home PointsFarid Jalali MD / May 2020
• Lung’s natural and physiologic protective response to SARS-CoV-2 induced alveolar capillary vasoconstriction and dead-space ventilation is characterized by alveolar hypocapnic bronchoconstriction at the level of the alveolar ducts to reduce a harmful alveolar expansion in these affected capillaries.
• Naturally, unaffected capillaries and corresponding alveoli will have a higher redistribution of ventilation, will exchange more CO2 into alveolar space, and will therefore have hypercapnic bronchodilation.
• This redistribution keeps the lung compliance preserved in the initial lung injury characterized mainly by dead-space ventilation, forming intrapulmonary shunts, without significant interstitial or alveolar edema.
Take Home PointsFarid Jalali MD / May 2020
• Compensatory lower inspiratory volumes characterize the patient’s response, associated with higher respiratory rate, and “shallow rapid breaths” without distress.
• This lower inspiratory volume is needed to prevent expansion of alveoli in the affected vasculopathic areas, as inappropriate expansion compounds the vasoconstriction in these affected alveolar capillaries.
• This will result in a compensatory tendency to develop hypocapnea on blood gas analysis, often concomitant with hypoxia as intrapulmonary shunts also begin to form as lung injury progress.
Take Home PointsFarid Jalali MD / May 2020
• Higher lung volumes, and positive pressure ventilation, disturb the fine balance maintained physiologically in the ventilatory redistribution pattern of the COVID19 lung, between high V/Q mismatch areas (poor perfusion, compensatory reduced ventilation to protect against the vasculopathy) and the compensating lower V/Q areas that safely receive higher ventilation in return.
• Therefore, mechanical ventilation may result in worsening of dead-space ventilation by constricting alveolar capillaries in the affected vasculopathic regions, and additionally result in worsening intrapulmonary shunting (next slide) due to reduced resistance in extra-alveolar vessels with higher lung volumes.
Take Home PointsFarid Jalali MD / May 2020
• In absence of endothelial stabilization, proper anticoagulation, and flow redistribution, lung Injury progresses to severe form by progressively worsening dead-space ventilation, resulting in intrapulmonary shunt development as described in the the diagrams.
• This advanced stage of lung injury is characterized by progressively diminished flow across the alveolar capillaries, resulting in higher flow across the formed intrapulmonary shunts, eventually culminating into progressive interstitial edema, progressive and diffuse alveolar damage, and alveolar fibrin thrombi deposition.
• Physiologically, this stage resembles “typical ARDS” where alveolar recruitment may be beneficial, but unlikely to reverse the vasculopathic disease process, inevitably resulting in high mortality. Pulmonary vasodilators and systemic vasoconstriction plausibly worsen hypoxia at this stage due to increasing flow across the intrapulmonary shunts.
Take Home PointsFarid Jalali MD / May 2020
• Through the action of body’s innate fibrinolytic system, lysis of microthrombi and reversal of flow to an area of injured endothelium may result in cycles of ischemia-reperfusion injury in the lung, mediated early on by monocytes and macrophages, and late by neutrophil activity.
• Reduction in leukocyte trafficking with corticosteroids and other therapeutics can be of value early on in the disease course to mitigate this ischemia-reperfusion injury.
• Late and sudden restoration of flow to a bed of alveolar capillaries that have had a prolonged and deep poor flow, usually in absence of proactive endothelial stabilization and proper anticoagulation, will inevitably result in a severe ischemia-reperfusion injury, significant interstitial and alveolar edema, and sudden demise.
• At this late of a stage in lung injury, ECMO may be the only solution available while pursuing lysis of microthrombi to restore alveolar capillary flow in a controlled fashion, while cardiopulmonary bypass is utilized to reduce risk of hemodynamic demise.